Amgen Inc. v. F. Hoffmann-LaRoche LTD et al
Filing
1139
BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. BENCH MEMORANDUM THAT DR. RICHARD FLAVELL PROPERLY TESTIFIED REGARDING HIS OPINION THAT CLAIM 7 OF THE 349 PATENT LACKS ENABLEMENT. (Attachments: #1 Exhibit A#2 Exhibit B)(Rizzo, Nicole)
<![CDATA[
Amgen Inc. v. F. Hoffmann-LaRoche LTD et al
Doc. 1139 Att. 1
Case 1:05-cv-12237-WGY
Document 1139-2
Filed 09/25/2007
Page 1 of 2
ÛÈØ×Þ×Ì ß
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS AMGEN INC., Plaintiff, v. F. HOFFMANN-LA ROCHE, LTD, ROCHE DIAGNOSTICS GmbH, and HOFFMANN-LA ROCHE INC., Defendants. Civil Action No. 05-cv-12237 WGY CONTAINS RESTRICTED ACCESS BLA/IND CONFIDENTIAL INFORMATION SUBJECT TO PROTECTIVE ORDER
FOURTH EXPERT STATEMENT OF RICHARD A. FLAVELL, PH.D. IN RESPONSE TO VARIOUS ARGUMENTS RAISED BY AMGEN'S EXPERTS
Dockets.Justia.com
Case 1:05-cv-12237-WGY
Document 1139-2
Filed 09/25/2007
Page 2 of 2
]]>
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?
